In an interview with the New York Times on Sunday, Tidmarsh said he was placed on administrative leave after raising concerns about the legal basis of a new program for the rapid approval of some drugs.
USFDA drug division chief George Tidmarsh resigns
Written By : Ruchika Sharma
Published On 2025-11-04 07:33 GMT | Update On 2025-11-04 07:33 GMT
George Tidmarsh, director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research (CDER), has resigned amid serious concerns about his personal conduct, a spokesperson for the Department of Health and Human Services said.
Tidmarsh was placed on administrative leave following the Office of the General Counsel and Office of the Inspector General were alerted to the concerns, the spokesperson told Reuters.
Appointed in July, Tidmarsh oversaw one of the FDA’s largest divisions, which regulates both prescription and over-the-counter medications.
"Secretary Kennedy expects the highest ethical standards from all individuals serving under his leadership and remains committed to full transparency," the HHS said.
He is also facing a lawsuit from Canadian drugmaker Aurinia Pharmaceuticals that accuses him of soliciting a bribe and damaging the company's stock with false statements as part of a revenge campaign against a former colleague, the Wall Street Journal reported on Sunday.
In September Tidmarsh questioned the safety and clinical benefit of Aurinia's lupus drug, Lupkynis, in a LinkedIn post that was later deleted. Aurinia said the drug is safe and effective, citing data from two major trials and the FDA's full approval in 2021.
The departure comes as U.S. health agencies undergo significant leadership changes under Health Secretary Robert F. Kennedy Jr.
Longtime vaccine official Peter Marks was ousted earlier this year, followed by gene-therapy head Nicole Verdun.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.